Literature DB >> 17020465

Novel vasopressin type 2 (AVPR2) gene mutations in Brazilian nephrogenic diabetes insipidus patients.

W L Boson1, T Della Manna, D Damiani, D M Miranda, M R Gadelha, B Liberman, H Correa, M A Romano-Silva, E Friedman, F F Silva, P A Ribeiro, L De Marco.   

Abstract

Nephrogenic diabetes insipidus (NDI) is an inherited disorder characterized by renal resistance to the antidiuretic effect of arginine vasopressin (AVP), resulting in polyuria, polydipsia, and hypoosmolar urine. In the vast majority of cases, NDI is associated with germ-line mutations in the vasopressin receptor type 2 gene (AVPR2) and in about 8% of the cases with the water channel aquaporin-2 gene (AQP-2) mutations. To date, approximately 277 families with 185 germ-line mutations in the AVPR2 gene have been described worldwide. In the present study, the AVPR2 gene was genotyped in eight unrelated Brazilian kindred with NDI. In five of these NDI families, novel mutations were noted (S54R, I130L, S187R, 219delT, and R230P), whereas three seemingly unrelated probands were found to harbor previously described AVPR2 gene mutations (R106C, R137H, R337X). Additionally a novel polymorphism (V281V) was detected. In conclusion, although NDI is a rare disease, the findings of mutations scattered over the entire coding region of the AVPR2 gene are a valuable model to determine structure function relationship in G-protein-coupled receptor related diseases. Furthermore, our data indicate that in Brazil the spectrum of AVPR2 gene mutations is "family specific".

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17020465     DOI: 10.1089/gte.2006.10.157

Source DB:  PubMed          Journal:  Genet Test        ISSN: 1090-6576


  7 in total

1.  V2 vasopressin receptor (V2R) mutations in partial nephrogenic diabetes insipidus highlight protean agonism of V2R antagonists.

Authors:  Kazuhiro Takahashi; Noriko Makita; Katsunori Manaka; Masataka Hisano; Yuko Akioka; Kenichiro Miura; Noriyuki Takubo; Atsuko Iida; Norishi Ueda; Makiko Hashimoto; Toshiro Fujita; Takashi Igarashi; Takashi Sekine; Taroh Iiri
Journal:  J Biol Chem       Date:  2011-12-05       Impact factor: 5.157

2.  Novel mutations associated with nephrogenic diabetes insipidus. A clinical-genetic study.

Authors:  Alejandro García Castaño; Gustavo Pérez de Nanclares; Leire Madariaga; Mireia Aguirre; Sara Chocron; Alvaro Madrid; Francisco Javier Lafita Tejedor; Mercedes Gil Campos; Jaime Sánchez Del Pozo; Rafael Ruiz Cano; Mar Espino; Jose Maria Gomez Vida; Fernando Santos; Victor Manuel García Nieto; Reyner Loza; Luis Miguel Rodríguez; Emilia Hidalgo Barquero; Nikoleta Printza; Juan Antonio Camacho; Luis Castaño; Gema Ariceta
Journal:  Eur J Pediatr       Date:  2015-04-23       Impact factor: 3.183

3.  Identification of a Novel Arginine Vasopressin Receptor 2 Mutation (p.V183M) in a Chinese Family with Nephrogenic Diabetes Insipidus.

Authors:  Ji-Shi Liu; Hao Huang; Jie-Yuan Jin; Ran Du; Chen-Yu Wang; Liang-Liang Fan
Journal:  Mol Syndromol       Date:  2020-03-28

4.  Analysis of a novel AVPR2 mutation in a family with nephrogenic diabetes insipidus.

Authors:  Sung-Dae Moon; Ju-Hee Kim; Joo-Yun Shim; Dong-Jun Lim; Bong-Yun Cha; Je-Ho Han
Journal:  Int J Clin Exp Med       Date:  2010-11-30

5.  Novel compound aquaporin 2 mutations in nephrogenic diabetes insipidus.

Authors:  Raphael D Liberatore Junior; Juliana G Carneiro; Franciele B Leidenz; Rachel Melilo-Carolino; Helena C Sarubi; Luiz De Marco
Journal:  Clinics (Sao Paulo)       Date:  2012       Impact factor: 2.365

6.  Nephrogenic diabetes insipidus (NDI): clinical, laboratory and genetic characterization of five Brazilian patients.

Authors:  Maria Helena Vaisbich; Juliana Carneiro; Wolfanga Bóson; Bruna Resende; Luiz De Marco; Rachel S Honjo; Chong Ae Kim; Vera H Koch
Journal:  Clinics (Sao Paulo)       Date:  2009-05       Impact factor: 2.365

7.  Four Japanese Patients with Congenital Nephrogenic Diabetes Insipidus due to the AVPR2 Mutations.

Authors:  Noriko Namatame-Ohta; Shuntaro Morikawa; Akie Nakamura; Kumihiro Matsuo; Masahide Nakajima; Kazuhiro Tomizawa; Yusuke Tanahashi; Toshihiro Tajima
Journal:  Case Rep Pediatr       Date:  2018-07-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.